The novel therapy of tirzepatide peptide represents a exciting development in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide878398.imblogs.net/91954892/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment